Document is current
Any future updates will be listed below
-
Authors
Hu, Yun
Revenko, Alexey
Barsoumian, Hampartsoum
Bertolet, Genevieve
Fowlkes, Natalie Wall
Maazi, Hadi
Green, Morgan Maureen
He, Kewen
Sezen, Duygu
Voss, Tiffany A.
Leyton, Claudia S Kettlun
Masrorpour, Fatemeh
Rafiq, Zahid
Puebla-Osorio, Nahum
Leuschner, Carola
MacLeod, Robert
Cortez, Maria Angelica
Welsh, James W. http://orcid.org/0000-0002-2255-8502
- License Information
-
More Information
Article History
Received: 22 January 2024
Accepted: 21 February 2024
First Online: 6 March 2024
Declarations
:
: All animal procedures were approved by the Institutional Animal Care and Use Committee at The University of Texas MD Anderson Cancer Center.
: All co-authors have given their consent to the submitted version of the manuscript for publication.
: J.W.W. is listed on a patent filed by MD Anderson regarding using mouse ASO for MER-TK treating cancer. J.W.W. is a co-founder of a company Oligo-Immune using ASO to macrophages targets including MER-TK for the treatment of pulmonary fibrosis. A.R., H.M., R.M. are employees of Ionis Pharmaceuticals Inc.
